ADD/ADHD

Top Story

FDA warns company for selling unapproved CBD products to treat Alzheimer’s, cancer, opioid withdrawal

FDA warns company for selling unapproved CBD products to treat Alzheimer’s, cancer, opioid withdrawal
July 23, 2019
In the Journals

Stimulant treatment prevents ADHD-related functional complications

July 23, 2019
Treatment with stimulant medications in children with ADHD was linked to a lower risk for functional complications mood, conduct and substance use disorders, and school…
In the Journals

Genetic risk for RA associated with early cognitive symptoms in children

July 8, 2019
Having an increased genetic risk for rheumatoid arthritis is associated with demonstrating hyperactivity and inattention symptoms from ages 4 to 16 years, as well as…
In the Journals

Methylphenidate treatment may not increase risk for psychotic events

June 25, 2019
Results from a large population-based cohort study in Sweden showed no evidence that initiation of methylphenidate treatment increased the risk for psychotic events…
More Headlines »
CME Article

The Role of Psychologists in Adult Attention-Deficit/Hyperactivity Disorder Testing

Psychiatric Annals, June 2017, Volume 47 Issue 6
Adults are commonly evaluated for attention-deficit/hyperactivity disorder (ADHD) in the outpatient psychiatric…
More »
CME

Adult ADHD: A Diagnostics Challenge and Treatment Dilemma: June 2017

Keck School of Medicine of USC and Psychiatric Annals

Paying attention to attention has led clinicians and researchers to understand the many ways attention can be…
More »
Video
Meeting News

VIDEO: New research shows additional symptom burden in adult ADHD

May 25, 2017
More »
Healio Jobs